Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas
Michael Cullen(NIHR Surgical Reconstruction and Microbiology Research Centre), Andrew Stanley(Birmingham City Hospital), Daniel Rea(University Hospitals Birmingham NHS Foundation Trust), Neil Steven(Swansea Bay University Health Board), Robert Huddart(Institute of Cancer Research), Mark Bower(Chelsea and Westminster Hospital), Peter Simmonds(University of Turku), Claire Gaunt(Cancer Research UK), Indrajit Fernando(NIHR Surgical Reconstruction and Microbiology Research Centre), Nicholas Stuart(VA Center for Clinical Management Research), Lucinda Billingham(University Hospitals Birmingham NHS Foundation Trust), Mark Hastings(Public Health Wales), Simon Gollins(Velindre Cancer Centre)
Cited by 423
Related Papers
Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes *
|Hepatology|2005|1.5k
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region
|Journal of General Virology|1993|1.4k
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
|Hepatology|2013|1.4k
The evolution of SARS-CoV-2
|Nature Reviews Microbiology|2023|1.2k